Document is current
Any future updates will be listed below
-
Authors
Hou, Yixuan J. http://orcid.org/0000-0002-8323-7243
Chiba, Shiho http://orcid.org/0000-0003-0415-6013
Leist, Sarah R. http://orcid.org/0000-0002-4989-5381
Meganck, Rita M. http://orcid.org/0000-0003-2799-3754
Martinez, David R.
Schäfer, Alexandra http://orcid.org/0000-0002-4760-4923
Catanzaro, Nicholas J.
Sontake, Vishwaraj
West, Ande
Edwards, Catlin E.
Yount, Boyd
Lee, Rhianna E. http://orcid.org/0000-0003-2039-1304
Gallant, Samuel C.
Zost, Seth J.
Powers, John
Adams, Lily http://orcid.org/0000-0001-7780-9973
Kong, Edgar F. http://orcid.org/0000-0001-8810-977X
Mattocks, Melissa http://orcid.org/0000-0001-8317-5284
Tata, Aleksandra
Randell, Scott H. http://orcid.org/0000-0001-5351-2841
Tata, Purushothama R. http://orcid.org/0000-0003-4837-0337
Halfmann, Peter http://orcid.org/0000-0002-1648-1625
Crowe, James E. Jr http://orcid.org/0000-0002-0049-1079
Kawaoka, Yoshihiro http://orcid.org/0000-0001-5061-8296
Baric, Ralph S. http://orcid.org/0000-0001-6827-8701
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA260543)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI151797, AI116484, AI158571, AI171292, AI157155)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL146557, HL153375)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI165977)
Japan Agency for Medical Research and Development (JP21wm0125002)
- License Information
-
More Information
Article History
Received: 3 April 2022
Accepted: 14 August 2023
First Online: 25 September 2023
Competing interests
: J.E.C. has served as consultant for Luna Biologics, Merck and GlaxoSmithKline, is a member of the Scientific Advisory Board of Meissa Vaccines and is Founder of IDBiologics. R.S.B. is a member of the advisory board of VaxArt and Invivyd and has collaborations with Takeda, Pfizer, Moderna, Ridgeback Biosciences, Gilead and Eli Lily. The Crowe laboratory at Vanderbilt University Medical Center has received sponsored research agreements from Takeda Pharmaceuticals, IDBiologics and AstraZeneca. Vanderbilt University has applied for patents pertaining to some of the antibodies described here. All other authors declare no competing interests.
